Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection just once a month.
Search results for "GLP-1"
GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use
A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications surging in popularity...
GLP-1 Drugs and Bone Health: Studies Highlight Fracture Risks in Elderly Patients
The GLP-1 receptor agonist class of drugs, widely used for the treatment of obesity and type 2 diabetes, has...
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack
New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity
It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care
GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...
Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound
Popular anti-obesity injections like Wegovy and Mounjaro reduce appetite and prolong feelings of fullness.
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Smart Snacking: Four Nutrient-Dense Options to Steady Blood Sugar and Prolong Satiety
Snacks are frequently vilified as the ultimate hurdle to effective blood sugar control.
Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop...